摘要
目的:研究六甲氧苄嗪(HMZ)对再灌注性心律失常的影响,同时探讨与氧自由基的关系。方法:用离体兔心灌注和SD大鼠在体心脏冠状动脉结扎,制造心肌缺血后再灌注两种模型。结果:HMZ4mg/kg和灌流浓度16μmol/L能使心律失常的发生率明显降低,并能提高红细胞内SOD的活力,血浆脂质过氧化代谢产物MDA含量由对照组的2.6±0.4nmol/L减少到1.8±0.2nmol/L。实验观察到具有剂量依赖性的负性频率作用。结论:HMZ具有较好的抗心律失常药理效应,其机理可能与降低心率和抑制自由基反应有关。
Objective: To investigate the effect of hexametazidine (HMZ) on reperfusioninduced arrhythmias (RA) after ischemia and the relationship to free oxygen radical. Methods: Myocardial ischemic and reperfusion isolated heart model was established by temporary occlusion of the coronary artery of SD rats. Results: The motality of RA was decreased significantly. Superoxide dismurase (SOD) activity of the red blood cell increased and plasma malondialdehyde level decreased when HMZ (16μmol/L,4mg/kg) was given iv. The negative chronotropic action of HMZ was dosedependent. Conclusion: HMZ can inhibit reperfusioninduced arrhythmias after ischemia. The mechanism may be related to its inhibiting effect on HR and response to free oxygen radical.
出处
《临床麻醉学杂志》
CAS
CSCD
1997年第6期328-330,共3页
Journal of Clinical Anesthesiology